Matisse Capital Tekla Life Sciences Investors Transaction History
Matisse Capital
- $205 Million
- Q1 2024
A detailed history of Matisse Capital transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Matisse Capital holds 34,333 shares of HQL stock, worth $484,095. This represents 0.23% of its overall portfolio holdings.
Number of Shares
34,333
Previous 10,000
243.33%
Holding current value
$484,095
Previous $134,000
248.51%
% of portfolio
0.23%
Previous 0.07%
Shares
7 transactions
Others Institutions Holding HQL
# of Institutions
80Shares Held
8.51MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY2.46MShares$34.7 Million0.58% of portfolio
-
Morgan Stanley New York, NY484KShares$6.83 Million0.0% of portfolio
-
1607 Capital Partners, LLC Richmond, VA481KShares$6.79 Million0.54% of portfolio
-
Allspring Global Investments Holdings, LLC431KShares$6.08 Million0.01% of portfolio
-
Aqr Arbitrage LLC Greenwich, CT387KShares$5.46 Million0.32% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...